Atomoxetine Asian Study in Adult Subjects With Attention-Deficit/Hyperactivity Disorder (ADHD)

Clinical trial NCT00636818 · COMPLETED

Trial details

NCT number: NCT00636818
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2008-03-01
Primary completion: 2008-09-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.